Skip to main content

Table 5 Characterization of HCC cases

From: IL-28B single nucleotide polymorphism as a predictor of hepatocellular carcinoma after treatment of chronic hepatitis C patients with direct acting antivirals

Character

HCC group

(N=50)

PVT

11 (22%)

Extrahepatic, LN spread

7 (14%)

Median period between EOT and HCC

18 m ± 6 m

Number of focal lesions

 Single

23 (46%)

 2–3

12 (24%)

 > 3

15 (30%)

BCLC

 Very early, early (0,A)

12 (24%)

 Intermediate (B)

16 (32%)

 Advanced (C)

4 (8%)

 Terminal (D)

18 (36%)